New HIV/AIDS vaccine enters phase II trials.

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English (US)
Pages (from-to)	138
Number of pages	1
Journal	The Lancet Infectious Diseases
Volume	5
Issue number	3
DOIs	https://doi.org/10.1016/s1473-3099(05)01300-9
Publication status	Published - Mar 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{50cdf2b67d93400090cb610c72e8838b,

title = "New HIV/AIDS vaccine enters phase II trials.",

author = "Khabir Ahmad",

year = "2005",

month = mar,

doi = "10.1016/s1473-3099(05)01300-9",

language = "English (US)",

volume = "5",

pages = "138",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - New HIV/AIDS vaccine enters phase II trials.

AU - Ahmad, Khabir

PY - 2005/3

Y1 - 2005/3

UR - https://www.scopus.com/pages/publications/15544386803

U2 - 10.1016/s1473-3099(05)01300-9

DO - 10.1016/s1473-3099(05)01300-9

M3 - Article

C2 - 15779123

AN - SCOPUS:15544386803

SN - 1473-3099

VL - 5

SP - 138

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 3

ER -